Montomoli E - Search Results

1

COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy.

Stufano A, Buonvino N, Trombetta CM, Pontrelli D, Marchi S, Lobefaro G, De Benedictis L, Lorusso E, Carofiglio MT, Vasinioti VI, Montomoli E, Decaro N, Lovreglio P. Stufano A, et al. Among authors: montomoli e. Vaccines (Basel). 2022 Jul 17;10(7):1137. doi: 10.3390/vaccines10071137. Vaccines (Basel). 2022. PMID: 35891301 Free PMC article.

2

Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.

Montomoli E, Khadang B, Piccirella S, Trombetta C, Mennitto E, Manini I, Stanzani V, Lapini G. Montomoli E, et al. Expert Rev Vaccines. 2012 May;11(5):587-94. doi: 10.1586/erv.12.24. Expert Rev Vaccines. 2012. PMID: 22827244 Review.

3

Is influenza A/H10N8 a potential candidate for the next pandemic?

Montomoli E, Trombetta CM. Montomoli E, et al. Pathog Glob Health. 2014 Jul;108(5):213. doi: 10.1179/2047772414Z.000000000215. Pathog Glob Health. 2014. PMID: 25175872 Free PMC article. No abstract available.

4

Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses.

Trombetta CM, Perini D, Vitale L, Cox RJ, Stanzani V, Piccirella S, Montomoli E. Trombetta CM, et al. Among authors: montomoli e. J Immunol Methods. 2015 Jul;422:95-101. doi: 10.1016/j.jim.2015.04.009. Epub 2015 Apr 22. J Immunol Methods. 2015. PMID: 25910832

5

Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, Julkunen I, Vuorela A, Vaarala O, Nohynek H, Pasini FL, Montomoli E, Trombetta C, Adams CM, Rothbard J, Steinman L. Ahmed SS, et al. Among authors: montomoli e. Sci Transl Med. 2015 Jul 1;7(294):294ra105. doi: 10.1126/scitranslmed.aab2354. Sci Transl Med. 2015. PMID: 26136476 Clinical Trial.

6

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E. Trombetta CM, et al. Among authors: montomoli e. Vaccines (Basel). 2014 Oct 13;2(4):707-34. doi: 10.3390/vaccines2040707. Vaccines (Basel). 2014. PMID: 26344888 Free PMC article. Review.

7

Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?

Trombetta C, Piccirella S, Perini D, Kistner O, Montomoli E. Trombetta C, et al. Among authors: montomoli e. Vaccines (Basel). 2015 Mar 18;3(1):172-85. doi: 10.3390/vaccines3010172. Vaccines (Basel). 2015. PMID: 26344952 Free PMC article. Review.

8

Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children.

Esposito S, Giavoli C, Trombetta C, Bianchini S, Montinaro V, Spada A, Montomoli E, Principi N. Esposito S, et al. Among authors: montomoli e. Vaccine. 2016 Jan 2;34(1):56-60. doi: 10.1016/j.vaccine.2015.11.019. Epub 2015 Nov 19. Vaccine. 2016. PMID: 26608327

9

Influenza immunology evaluation and correlates of protection: a focus on vaccines.

Trombetta CM, Montomoli E. Trombetta CM, et al. Among authors: montomoli e. Expert Rev Vaccines. 2016 Aug;15(8):967-76. doi: 10.1586/14760584.2016.1164046. Epub 2016 Mar 25. Expert Rev Vaccines. 2016. PMID: 26954563 Review.

10

Fighting Neisseria meningitidis: past and current vaccination strategies.

Piccini G, Torelli A, Gianchecchi E, Piccirella S, Montomoli E. Piccini G, et al. Among authors: montomoli e. Expert Rev Vaccines. 2016 Nov;15(11):1393-1407. doi: 10.1080/14760584.2016.1187068. Epub 2016 May 27. Expert Rev Vaccines. 2016. PMID: 27158988 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page